Categories
All News Coronavirus COVID-19 Market Impact Industry Analytics Market Reports

Protein Therapeutics Market High Players Gift Within The Trade House With Rate Of Growth & Forecast To 2026

Global Protein therapeutics market was valued at $140,109 million in 2016, and is projected to reach $217,591 million by 2023, growing at a CAGR of 6.5% from 2017 to 2023. The monoclonal antibodies product segment occupied the highest market share of the market in 2016.

Therapeutic proteins are an important class of drugs, which serve patients in need of novel therapies. Approved recombinant protein therapeutics are developed to treat a wide array of clinical indications, including cancers, genetic disorders, infectious diseases, and metabolic disorders.

Do Enquiry for Sample Report @  https://www.alliedmarketresearch.com/request-sample/60

The major factors that drive the growth of the global protein therapeutics market include introduction & application of new plasma-derived therapies, surge in prevalence of chronic & life-threatening diseases, and rise in awareness among populace regarding the high efficiency of protein therapeutics. However, high cost of protein therapies and complex reimbursement scenario impede the market growth. Conversely, increase in novel indications for known protein therapeutics and untapped emerging markets are anticipated to provide lucrative opportunities for the manufacturers in this industry.

The metabolic disorders application generated the highest revenue of $27,837 million in 2016, and is anticipated to continue this trend in the future. This is attributed to the requirement for quality drugs and versatile therapies for disease treatment, especially diabetes. Cancer application is anticipated to grow at the highest CAGR of 8.2% from 2017 to 2023.

North America held the highest market share of $72,899 million in 2016, owing to high prevalence rate of cancer and other chronic diseases, owing to rise in adoption of these drugs and increase in awareness about protein therapeutics. Asia-Pacific is expected to grow at the highest CAGR of 7.6% during the forecast period, owing to rapid industrialization in the area, increase in disposable income, and upsurge in government initiatives to modernize healthcare infrastructure.

Do Enquiry before purchasing Report @  https://www.alliedmarketresearch.com/purchase-enquiry/60

KEY FINDINGS OF THE STUDY 

  • The monoclonal antibody segment is anticipated to grow at the highest CAGR from 2017 to 2023.
  • The cancer application segment is expected to witness the highest growth rate during the forecast period.
  • Metabolic disease application segment is anticipated to occupy the largest share in the protein therapeutics market.
  • North America dominated the global protein therapeutics market, and is projected to grow at a CAGR of 6.1%.

The report provides extensive competitive analysis and profiles of key market players, such as Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer Inc., and Sanofi. Other players (profiles not included in the report) in the value chain analysis include, Biogen, Inc., CSL Behring, and Genentech, Inc.

Categories
All News Coronavirus COVID-19 Market Impact Industry Analytics Market Reports

Protein Labeling Market Is Expected to Witness a Steady Growth by 2026

Protein labeling market would reach $5,350 million by 2022 from $2,002 million in 2015, growing at a CAGR of 14.9% during the forecast period. Reagents segment is estimated to dominate the global protein labeling market throughout the analysis period. Majority of the global protein labeling market share was captured by U.S. in 2015.

Protein labeling is an effective technique to study protein structure, function, and functioning of genes. The global protein labeling market has become prominent due to increase in expenditure on R&D, escalation in proteomics research, and rise in the healthcare expenses. Moreover, the launch of new technologies has boosted this market.

Download free sample Report @ https://www.alliedmarketresearch.com/request-sample/1767

Protein labeling technique is a secondary research tool for proteomic analysis, and is used for research and diagnostic purposes in biotechnology and pharmaceuticals industries. Moreover, with the rise in the prevalence of chronic diseases such as cancer, the need for prevention, diagnosis, and treatment of such diseases is on the rise. Consequently, the demand for such techniques is anticipated to increase. Alternatively, lack of skilled professionals, limited applications of protein labeling products along with high costs of reagents, kits, and other protein labeling services are the key factors that could impede the market growth.

Amongst the labeling methods, the in vivo labeling segment dominates the market with more than half of the global protein labeling market in 2015. This is mainly attributed to ease of availability of products and reagents and the stability of this method. However, bioorthogonal labeling segment is expected to be the fastest growing segment. This is attributed to the fact that this method of proteins labeling can be carried out in living cells without hindering the biochemical functioning of the cell.

By product types, the reagents segment dominated the global protein labelling market. Reagents accounted for about 60% share in 2015 and are frequently used in different protein labeling procedures, from sample preparation to washing and incubation. As the objective of every research is different, the researcher cannot use conventional products for different methodologies. Thus, the growth in demand for customized protein labeling services segment have lead it to become the fastest growing segment during the forecast period.

Discount on Purchase @ https://www.alliedmarketresearch.com/purchase-enquiry/1767

Key findings of the Protein Labeling Market study:

  • Nanoparticle labeling segment is estimated to exhibit a CAGR of 17.4%, among in vitro labeling.
  • Fluorescence Microscopy segment will exhibit a CAGR of 16.1% in LAMEA region.
  • Research laboratories segment holds two-thirds of the share in the end-user protein labeling market.
  • Photoreactive labeling segment for in vivo protein labeling is projected to be the fastest growing segment from 2016 to 2022.
  • Mexico was the smallest economy market in 2015, and is projected to grow at a CAGR of 15.7% through 2022.

Based on geography, North America generated the highest revenue in 2015, accounting for the majority of the share of global protein labeling market, due to various technological advancements, rise in R&D investments, and surge in demand for protein labeling products. Furthermore, North America is estimated to continue to dominate the world market, owing to rise in technological innovations and significant rise in funding. The Asia-Pacific region is expected to be the fastest growing segment, owing to the increased demands of emerging economies such as Japan and China and rise in healthcare expenditure.

The key developmental strategies adopted by leading market players are product launches, collaborations, and partnerships. The prominent market players profiled in the report include General Electric Company, Kaneka Corporation, LI-COR, Inc., Merck & Co., Inc., New England Biolabs, Inc., PerkinElmer, Inc., Promega Corporation, F. Hoffmann-LA Roche AG, Seracare Life Sciences, Inc., and Thermo Fisher Scientific, Inc.

Categories
All News Analysis Forecast Coronavirus COVID-19 Market Impact Growth Prospects Industry Analytics Market Outlook Market Reports NASA World

Protein Expression Market Size Prognosticated to Perceive a Thriving Growth by 2026 | Becton, Dickinson & Company

The global protein expression market is expected to reach $4 billion by 2026, registering a CAGR of 10.2% from 2018 to 2026, in terms of value.

Global Protein Expression Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/6463

Protein expression is defined as a biotechnological procedure, which includes generation of precise proteins. These proteins are formed through manipulation of gene expression in organisms of interest. The procedure leads to expression of large amounts of recombinant gene in organisms. Furthermore, this has led to many possibilities of expression and isolation of heterologous proteins for research, clinical, and industrial purposes. This, in turn, has led to advancements in genetic engineering and recombinant technologies. Significant advancements in the field of biotechnology have enabled expression and isolation of recombinant proteins on large scale. Some of products which are used to perform protein expression present in the market include reagents, expression vectors, competent cells, instruments, and others. These products are used in designing therapeutics and conducting research related to medicines.

The factors that boost the growth of the protein expression market include surge in geriatric population and increase in prevalence of chronic diseases such as cancer. Moreover, increase in spending on protein research also fuel the growth of the protein expression market. However, high monetary inputs associated with the production of protein products restrict the growth of the market. In addition, significant shortage of trained healthcare professionals and lack of local expertise also restrains the market. Conversely, emergence of microfluids, along with growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

The global protein expression market is segmented based on product, application, and region. Based on product, the market is bifurcated into reagents, expression vectors, competent cells, instruments, and services. By application, it is divided into therapeutic, industrial, and research. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, France, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6463

The Major Key Players Are:

  • Agilent Technologies, Inc
  • Becton
  • Dickinson & Company
  • Bio Rad Laboratories
  • GenScript Biotech Corporation
  • LifeSensors Inc.
  • Merck KGaA
  • Promega Corporation
  • QIAGEN N.V.
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research